deltatrials
Active Not Recruiting PHASE1 INTERVENTIONAL 1-arm NCT02285192

Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Cervical Cancer Endometrial Cancer
Interventions 18F-Fluorodeoxyglucose (18F-FDG) PET/CT imaging PET/MRI imaging
Updated 20 times since 2017 Last updated: Dec 23, 2025 Started: Nov 30, 2014 Primary completion: Nov 30, 2026 Completion: Nov 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02285192, this PHASE1 trial focuses on Cervical Cancer and Endometrial Cancer and remains ongoing. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 20 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Oct 2017 · 6 months · monthly snapshot~Oct 2017 – ~Mar 2018 · 5 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Apr 2019 · 7 months · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Feb 2020 · 9 months · monthly snapshot~Feb 2020 – ~Dec 2020 · 10 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshot~Jan 2022 – ~Feb 2023 · 13 months · monthly snapshot~Feb 2023 – ~Aug 2023 · 6 months · monthly snapshot~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – ~Jan 2026 · 5 months · monthly snapshot~Jan 2026 – present · 6 months · monthly snapshot

Change History

20 versions recorded

  1. Jan 2026 — Present [monthly]

    Active Not Recruiting PHASE1

  2. Aug 2025 — Jan 2026 [monthly]

    Active Not Recruiting PHASE1

  3. Sep 2024 — Aug 2025 [monthly]

    Active Not Recruiting PHASE1

  4. Aug 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1

  5. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting PHASE1

▶ Show 15 earlier versions

  1. Aug 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1

  2. Feb 2023 — Aug 2023 [monthly]

    Active Not Recruiting PHASE1

  3. Jan 2022 — Feb 2023 [monthly]

    Active Not Recruiting PHASE1

  4. Jan 2021 — Jan 2022 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  5. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  6. Feb 2020 — Dec 2020 [monthly]

    Recruiting PHASE1

  7. May 2019 — Feb 2020 [monthly]

    Recruiting PHASE1

  8. Apr 2019 — May 2019 [monthly]

    Recruiting PHASE1

  9. Sep 2018 — Apr 2019 [monthly]

    Recruiting PHASE1

  10. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE1

  11. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

  12. Oct 2017 — Mar 2018 [monthly]

    Recruiting PHASE1

  13. Apr 2017 — Oct 2017 [monthly]

    Recruiting PHASE1

  14. Feb 2017 — Apr 2017 [monthly]

    Recruiting PHASE1

  15. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations